Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

Clinical trial NCT04145622 · RECRUITING

Trial details

NCT number: NCT04145622
Sponsor: Daiichi Sankyo
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Malignant Solid Tumor

Start date: 2019-11-03
Primary completion: 2027-04-30
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.